Aesthetics

In part 4 of our interview with Whitney Bowe, MD, she dives into the multiple methods physicians can use to treat adverse reactions from the COVID-19 vaccine in their dermal filler patients.

Recent reports have been surfacing in regard to adverse reactions in dermal fillers patients who have also received the COVID-19 vaccine. Whitney Bowe, MD, New York City, New York, discusses this phenomenon and provides some tips for preventing and treating these side effects.

Allergan announces the launch of Coolsculpting Elite, along with seven new C-shaped applicators.

Allergan Aesthetics plans on expanding its CoolSculpting portfolio with the launch of its novel CoolSculpting Elite device that targets visible fat in nine different areas of the body.

In part 3, Whitney Bowe, MD, suggests how physicians should manage their patients' expectations when it comes to HA fillers and the COVID-19 vaccine.

Galderma announced the launch of its Face for Change program that allows abobotulinumtoxinA (Dysport) patients to give back with each treatment received to either Dress for Success or The Skin Cancer Foundation.

Results of a recent in vitro study show that a novel topical cosmetic vehicle successfully stabilizes and preserves platelet-rich plasma (PRP).

In the second part of our interview with Whitney Bowe, MD, she reveals the type of fillers that have been linked to adverse reactions in dermal filler patients who have received the COVID-19 vaccine.

This week, consumer magazines highlight the impact of TikTok skinfluencers, keeping a skin diary, and more.

In this expert interview, Whitney Bowe, MD, explains the rare adverse reactions the medical community has recently been seeing in dermal filler patients who received the COVID-19 vaccine.

This week in aesthetics, a study examines tofacitinib to treat alopecia areata, Dr. Michael Kluska compares Renuvion (J-Plasma) versus Bodytite, and more.

The American Society of Dermatologic Surgery releases its annual survey showing the continued popularity of minimally invasive and nonsurgical treatments.

A 2017 study examines the long-term efficacy of JAK 1/3 inhibitor, tofacitinib, for treatment of alopecia areata and its variants.

This week, consumer magazines highlight the science behind the longevity movement for aging, dermarolling for hair loss, and more.

This week in aesthetics, we highlight collagen supplements for anti-aging, plastic surgery safety during COVID-19, and more.

Merz and Candela announce the launch of a commercial collaboration to provide one of the broadest medical aesthetics portfolios in the world.

A recent study examines plastic surgery safety data to verify COVID-19 protocols.

For aesthetic physicians interested in incorporating regenerative medicine into the practice, we’ve compiled a list of 5 articles to inform and inspire, including novel applications and how to get started.

BENEV recently announced positive results in its study examining the combination therapy of human adipose tissue stem cell-derived exosomes and fractional CO2 laser for the treatment of acne scars.

Allergan Aesthetics has entered into a warrant agreement that will give the company an option to acquire Cypris Medical following the completion of a clinical trial evaluating Cypris’ Xact device.

Endo Aesthetics announces the launch of its new, “Really Cellulite” campaign to eliminate the shame associated with cellulite.

Researchers examine the results of collagen supplements for both short- and long-term anti-aging use.

A recent study shows an association between finasteride use and psychological adverse events (AEs) including suicidality. Dermatologists should weigh benefits and risks carefully when considering finasteride for certain patients with hair loss, according to one expert.

This week, consumer magazines highlight PCOS-related cystic acne, psychodermatology, and more.

This week in aesthetics, a study examines energy device plume, the U.S. International Trade Commission upholds a 21-month ban on Evolus’ Jeuveau, and more.